Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The new WHO classification of gastrointestinal neuroendocrine tumors and immunohistochemical expression of somatostatin receptor 2 and 5
Oana Popa, Sorina Tãban, Stelian Pantea, et al.
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 4
Open Access | Times Cited: 57

Showing 26-50 of 57 citing articles:

Mismatch repair deficiency and MUTYH variants in small intestine-neuroendocrine tumors
Noah C. Helderman, Fadwa A. Elsayed, Tom van Wezel, et al.
Human Pathology (2022) Vol. 125, pp. 11-17
Open Access | Times Cited: 5
Molecular factors, diagnosis and management of gastrointestinal tract neuroendocrine tumors: An update
Efstathios Theodoros Pavlidis, T. Pavlidis
World Journal of Clinical Cases (2022) Vol. 10, Iss. 27, pp. 9573-9587
Open Access | Times Cited: 5
Real-world comparison of healthcare resource utilization and costs of [177Lu]Lu-DOTA-TATE in patients with progressive neuroendocrine tumors in England: a matched cohort analysis using data from the hospital episode statistics dataset
Tony Cox, Matthew O’Connell, Oscar Leeuwenkamp, et al.
Current Medical Research and Opinion (2022) Vol. 38, Iss. 8, pp. 1305-1317
Closed Access | Times Cited: 4
Mixed neuroendocrine–non‐neuroendocrine neoplasm associated with autoimmune gastritis
Naoko Mori, Masanori Hongo, Shizuki Takemura, et al.
Clinical Case Reports (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 3
Standardized Uptake Values on SPECT/CT: A Promising Alternative Tool for Treatment Evaluation and Prognosis of Metastatic Neuroendocrine Tumours
Mirela Gherghe, Alexandra Maria Lazăr, Laurentiu Simion, et al.
Diagnostics (2023) Vol. 13, Iss. 2, pp. 318-318
Open Access | Times Cited: 1
Evaluating the Presence of a Stage IV Low-Grade Well-Differentiated Neuroendocrine Tumor of the Ileocecum: A Case Report with Evaluation of Staging Protocol of Neuroendocrine Tumors and Treatment Options Based on Current Available Evidence
Vineet Madishetty, A Starr, Quyen D. Chu, et al.
Case Reports in Surgery (2023) Vol. 2023, pp. 1-7
Open Access | Times Cited: 1
Localized Colonic Small-Cell Carcinoma with Pathological Complete Response after Neoadjuvant Cisplatin and Etoposide: A Case Report
V. Navarro, Íñigo Martínez Delfrade, Belén De Frutos González, et al.
Current Oncology (2023) Vol. 30, Iss. 9, pp. 8426-8433
Open Access | Times Cited: 1
High-Grade Sinonasal Small Cell Neuroendocrine Carcinoma in a Patient With Xeroderma Pigmentosum: A Case Report
Abdulaziz M Alabdulkareem, Naif H. Alotaibi, Abdulaziz A. Almobarak, et al.
Ear Nose & Throat Journal (2024)
Open Access
Prognostic marker of immunohistochemistry-based somatostatin receptors 2 and 5 H-scores in patients with pancreatic neuroendocrine neoplasms
Satomi Kono, Hidekazu Nagano, Yuki Taki, et al.
Endocrine and Metabolic Science (2024) Vol. 15, pp. 100176-100176
Open Access
Synchronous early rectal adenocarcinoma and neuroendocrine tumour: A treatment strategy
Dinesh Alagoo, Harivinthan Sellappan, Saravana Kumar Rajanthran, et al.
Polish Annals of Medicine (2024), pp. 1-4
Open Access
Long-term clinical outcomes of [177Lu]Lu-DOTATATE in patients with metastatic neuroendocrine tumors
Sabah Iqbal, Eric Zhuang, Moses S. Raj, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Larger Tumor Size and Elevated Serum Chromogranin A Levels Predict Metastatic Disease on DOTATATE Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors
Amanda Labora, Takayuki Shimizu, Alexandra Moore, et al.
Annals of Surgical Oncology (2024) Vol. 31, Iss. 10, pp. 6875-6882
Closed Access
Clinical Evaluation of Response to Octreotide and Chemotherapy in High-Grade Malignant Neuroendocrine Tumors and Promising In Vitro Preclinical Results with Pasireotide
Kevin Doello, María Ángeles Chico, Francisco Quiñonero, et al.
Medicina (2024) Vol. 60, Iss. 7, pp. 1039-1039
Open Access
Hepatic cholera: a case report with literature review
Gaurav Khatana, Lal Krishna Unnikrishnan, Sandesh Kolassery, et al.
Egyptian Liver Journal (2024) Vol. 14, Iss. 1
Open Access
Postoperative 68Ga‐DOTATATE positron emission tomography has a low yield in incidental appendiceal neuroendocrine tumours
Emilie Pauvert, George Larcos
ANZ Journal of Surgery (2024)
Open Access
Effect of Ki-67 proliferation index on survival in large cell neuroendocrine carcinoma of the lung
Mustafa Emre Duygulu, Esra Aşık, Mehmet Akif Tükenmez, et al.
Revista da Associação Médica Brasileira (2024) Vol. 70, Iss. 9
Open Access
Treatment sequencing in gastroenteropancreatic neuroendocrine tumors
Philipp Melhorn, Markus Raderer, Barbara Kiesewetter
memo - Magazine of European Medical Oncology (2024) Vol. 17, Iss. 4, pp. 257-262
Open Access
Critical considerations for the management of gastrointestinal mixed neuroendocrine non-neuroendocrine neoplasms and pure neuroendocrine carcinomas
T. Pavlidis, I. Galanis, T. Pavlidis
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 12, pp. 4559-4564
Closed Access
Stereotactic radiosurgery for pancreatic neuroendocrine tumor brain Metastases: Systematic review and Illustrative case presentation
Paul M Harary, Yusuke Hori, Shreyas Annagiri, et al.
Journal of Clinical Neuroscience (2024) Vol. 130, pp. 110927-110927
Closed Access
Characterization of Somatostatin Receptor 2 Gene Expression and Immune Landscape in Sinonasal Malignancies
Elisabetta Xue, Dara Bracken-Clarke, Harris Benjamin Krause, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 3931-3931
Open Access
Treatment tactics of new NET G3 subgroup in first line of therapy
Е. В. Евдокимова, Е. В. Артамонова, V. V. Delectorskaya, et al.
Medical alphabet (2022), Iss. 37, pp. 20-24
Closed Access | Times Cited: 2
Immunohistochemical Markers and SPECT/CT Somatostatin-Receptor (99MTCTEKTROTYD) Uptake in Well and Moderately Differentiated Neuroendocrine Tumors
Marius Badan, Doina Piciu
Acta Endocrinologica (Bucharest) (2022) Vol. 18, Iss. 4, pp. 523-530
Open Access | Times Cited: 1
Theranostics in Neuroendocrine Tumors
Shankar Vallabhajosula
Springer eBooks (2023), pp. 609-654
Closed Access
Post-Topotecan Mixed Response and ‘Redifferentiation-akin’ Phenomenon on Dual Tracer PET-CT in Multiple Treatment-Resistant Metastatic Neuroendocrine Neoplasm
Sarvesh Loharkar, Sandip Basu
World Journal of Nuclear Medicine (2023) Vol. 22, Iss. 02, pp. 130-134
Open Access
A Case of Familial Appendiceal Neuroendocrine Tumor
Souad Ghattas, Ribal Aby Hadeer, Hani Maalouf, et al.
ACG Case Reports Journal (2023) Vol. 10, Iss. 8, pp. e01121-e01121
Open Access

Scroll to top